Wave Life Sciences
46 hedge funds and large institutions have $456M invested in Wave Life Sciences in 2016 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 2 closing their positions.
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
80% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 10
55% more capital invested
Capital invested by funds: $294M → $456M (+$162M)
18% more funds holding
Funds holding: 39 → 46 (+7)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$3.8M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$3.36M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$2.68M |
| 4 |
Jennison Associates
New York
|
+$1.78M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.37M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$9.3M |
| 2 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
-$5.73M |
| 3 |
Goldman Sachs
New York
|
-$931K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$757K |
| 5 |
Renaissance Technologies
New York
|
-$739K |
WVE Hedge Fund Activity: Q3 2016 in Review
46 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q3 2016, worth a combined $456M — up 55% from $294M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new WVE positions and 2 closed out — a net gain of 7 holders — while 18 added to existing stakes and 10 trimmed.
The largest buyer was Perceptive Advisors, adding an estimated $3.8M. The largest seller was Redmile Group, cutting an estimated $9.3M.
- 46 institutional investors held Wave Life Sciences (WVE) as of Q3 2016, up from 39 in Q2 2016.
- Funds reported $456M of Wave Life Sciences stock for Q3 2016, up 55% quarter-over-quarter.
- 9 funds opened new Wave Life Sciences positions in Q3 2016 and 2 closed out, a net change of +7 holders.
- The largest Wave Life Sciences buyer in Q3 2016 was Perceptive Advisors, an estimated $3.8M added.
- The largest Wave Life Sciences seller in Q3 2016 was Redmile Group, an estimated $9.3M sold.
Based on aggregated 13F filings for Q3 2016.